CSIMarket Company Name, Ticker, Customers, else..
 
Cyteir Therapeutics Inc   (NASDAQ: CYT)
 

CYT's Market share relative to its competitors, as of Q3 2023

As of Q3 2023 (Revenue in Millions of $)

Date modified: 2026-08-29T06:32:56+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months
Q3 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE
A Quarter Before
Q2 2023
Cyteir Therapeutics Inc 1,545.00 22.22% 0.00 % 0.00 %
Madrigal Pharmaceuticals Inc 1,132.49 16.29% 23.28% 22.50%
Supernus Pharmaceuticals inc 776.83 11.17% 14.00% 15.01%
Blueprint Medicines Corporation 562.12 8.09% 9.55% 10.58%
Hutchmed china Limited 548.51 7.89% 7.89% 0.00%
Rigel Pharmaceuticals Inc 299.77 4.31% 5.03% 4.25%
57 more competitors available

Sign in to see all competitors for Cyteir Therapeutics Inc .

Sign In Create Free Account



CYT's Market share relative to its competitors, as of Q3 2023 within the Major Pharmaceutical Preparations Industry
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Cyteir Therapeutics Inc 23.33% 29.73% 0.00 % 0.00 %
Madrigal Pharmaceuticals Inc 17.10% 14.21% 24.86% 23.92%
Supernus Pharmaceuticals inc 11.73% 10.66% 14.95% 15.96%
Blueprint Medicines Corporation 8.49% 7.54% 10.20% 11.25%
Hutchmed china Limited 8.28% 9.34% 8.28% 9.34%
Rigel Pharmaceuticals Inc 4.53% 4.36% 5.37% 4.52%
55 more companies available

Sign in to see all industry competitors for Cyteir Therapeutics Inc .

Sign In Create Free Account



CYT's Market share relative to its competitors, as of Q3 2023 within the Healthcare Sector
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Cyteir Therapeutics Inc 22.22% 28.47% 0.00 % 0.00 %
Madrigal Pharmaceuticals Inc 16.29% 13.61% 23.28% 22.50%
Supernus Pharmaceuticals inc 11.17% 10.21% 14.00% 15.01%
Blueprint Medicines Corporation 8.09% 7.23% 9.55% 10.58%
Hutchmed china Limited 7.89% 8.95% 7.89% 8.95%
Rigel Pharmaceuticals Inc 4.31% 4.18% 5.03% 4.25%
57 more companies available

Sign in to see all sector competitors for Cyteir Therapeutics Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Cyteir Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Cyteir Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.